The company's flagship product, Angioshield, delivers temporary structural support to veins used as arterial vein grafts. Neograft's cardiac device creates a support layer around the vein using electrospinning, allowing nutrients and new cells to migrate through without deforming its natural shape. Founded in 2009 and based in Taunton, Massachusetts, Neograft Technologies is focused on improving vein performance in coronary artery bypass.